LONDON (Reuters) - Things are looking up for GSK and its chief Emma Walmsley as the British drugs giant prepares to spin off its consumer health business on Monday in London’s biggest listing in a ...
LONDON (Reuters) - British drugmaker GSK spun off its consumer health business on Monday in the biggest listing in Europe for more than a decade, but the unit's market value of 30.5 billion pounds ...
GSK is sticking to its plan to gradually monetize its stake in Haleon, the consumer health business the British pharma giant spun off in 2022. GSK has collected about 978 million pounds ($1.24 billion ...
Pfizer plans to sell its 32% stake in GSK’s consumer health venture, Haleon, after its spinoff into an independent company is finalized in July. Despite previous signals from Pfizer that it indicated ...
GSK plc GSK recently announced that it has completed the spin-off of its consumer healthcare segment into a new standalone company called Haleon. Following the demerger, Haleon is the world’s largest ...
GSK’s consumer healthcare spinoff will launch on the London stock market on July 18 with a new name, a new CEO and around 10.3 billion pounds of debt. That's according to a report on This is Money, a ...
Close on the heels of an M&A deal, GlaxoSmithKline plc (NYSE:GSK) confirmed the spin-off of the consumer healthcare business it jointly owns with U.S. pharma giant Pfizer, Inc. (NYSE:PFE). What ...
GSK plc (NYSE:GSK) is one of the best affordable healthcare stocks to buy now. GSK plc (NYSE:GSK) announced on December 19 an ...
RESEARCH TRIANGLE PARK – No longer known officially as GlaxoSmithKline but GSK – or “The new GSK” as the drug giant describes itself – emerges today as its consumer health business is spun off as ...
The comprehensive solar panel project is designed to generate electricity equivalent to more than 70% of the Oak Hill site’s annual usage and reduce its carbon footprint by 60% FRAMINGHAM, Mass. & OAK ...
LONDON, June 1 (Reuters) - Pfizer (PFE.N), opens new tab plans to sell its 32% stake in Haleon, its consumer health venture with British drugmaker GSK (GSK.L), opens new tab, after the business lists ...
Q1 adjusted EPS 32.8 pence vs forecast 30 pence Q1 turnover 9.78 bln stg vs forecast 9.15 bln Consumer health business listing on track for July Shares rise about 1.7% April 27 (Reuters) - GSK (GSK.L) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results